Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cervista HPV HR test for cervical cancer screening: a comparative study in the Catalonian population.

Archives of pathology & laboratory medicine - 1 Feb 2015

Alameda Francesc, Garrote Leia, Mojal Sergi, Sousa Carlos, Muset Mercè, LLoveras Belen, Bellosillo Beatriz, Saldanha Conceçao, Carreras Ramon, Serrano Sergi

Abstract excerpt

CONTEXT: Almost all cervical cancers are related to the human papillomavirus (HPV). Future strategies for cervical cancer screening will be based on HPV detection. The Hybrid Capture 2 (HC2) test is currently the most widely used method to screen for HPV. OBJECTIVE: To test the performance of the Cervista HPV HR test for cervical screening. DESIGN: We examined 875 cervical samples by HC2 and Cervista. Of these,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alphapapillomavirus
Share to False Negative Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Papanicolaou Test

Share to Papillomavirus Infections

Share to Reagent Kits, Diagnostic

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 25611107
DOI: 10.5858/arpa.2014-0012-OA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cervista HPV HR test for cervical cancer screening: a comparative study in the Catalonian population.PMID 25611107Read ↗

Human Papillomavirus Testing with the Hybrid Capture 2 Assay and PCR as Screening ToolsSemantic proximity Read ↗

Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.Semantic proximity Read ↗

Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening.Semantic proximity Read ↗

Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.Semantic proximity Read ↗

Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.Semantic proximity Read ↗

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.Semantic proximity Read ↗

Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.Semantic proximity Read ↗

Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.Semantic proximity Read ↗

Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 womenSemantic proximity Read ↗

Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are ReproducibleSemantic proximity Read ↗

Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.Semantic proximity Read ↗

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.